Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Burns. 2010 Aug 7;37(1):61–68. doi: 10.1016/j.burns.2010.07.007

Figure 3.

Figure 3

Subjective pain and fun ratings (0 to 100 GRS assessment) during the control condition (standard pharmacologic therapy without virtual reality – white bars) and the virtual reality condition (standard pharmacologic therapy plus immersive virtual reality – black bars) on multiple study days. Virtual reality results in a persistent decrease in “worst pain” (panel A), “time spent thinking about pain” (panel B), and “pain unpleasantness” (panel C) over several days of therapy (* p < 0.05). Virtual reality also results in a persistent increase in “fun” (panel D) over several days of therapy (* p < 0.05).